We also observed a trend of increased mRNA levels of PPARα in cancer patients compared to controls (p = 0.055) (Fig. 1C), whereas no difference was found in MCP1 mRNA levels between the two groups (Fig. 1D). This evidence concerns the gene CCL2 and cancer.